Not logged inPrognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024)
Hartlapp, I.; Valta-Seufzer, D.; Siveke, J. T.; Alguel, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V. .png)
Share.png)
Save Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024)Hartlapp, I.; Valta-Seufzer, D.; Siveke, J. T.; Alguel, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V. Share Save Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)da randomized phase II trial of the AIO pancreatic cancer groupSeufferlein, T.; Uhl, W.; Kornmann, M.; Alguel, H.; Friess, H.; Koenig, A.; Ghadimi, M.; Gallmeier, E.; Bartsch, D. K.; Lutz, M. P.; Metzger, R.; Wille, K.; Gerdes, B.; Schimanski, C. C.; Graupe, F.; Kunzmann, V.; Klein, I.; Geissler, M.; Staib, L.; Waldschmidt, D.; Bruns, C.; Wittel, U.; Fichtner-Feigl, S.; Daum, S.; Hinke, A.; Blome, L.; Tannapfel, A.; Kleger, A.; Berger, A. W.; Kestler, A. M. R.; Schuhbaur, J. S.; Perkhofer, L.; Tempero, M.; Reinacher-Schick, A. C.; Ettrich, T. J. Share Save Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multi-agent induction chemotherapy: Results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)Hartlapp, I.; Valta-Seufzer, D.; Siveke, J.; Alguel, H.; Goekkurt, E.; Siegler, G. M.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C-T.; Stang, H. A.; Heinemann, V.; Kunzmann, V. Share Save Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemiaMueller-Tidow, C.; Tschanter, P.; Roellig, C.; Thiede, C.; Koschmieder, A.; Stelljes, M.; Koschmieder, S.; Dugas, M.; Gerss, J.; Butterfass-Bahloul, T.; Wagner, R.; Eveslage, M.; Thiem, U.; Krause, S. W.; Kaiser, U.; Kunzmann, V.; Steffen, B.; Noppeney, R.; Herr, W.; Baldus, C. D.; Schmitz, N.; Goetze, K.; Reichle, A.; Kaufmann, M.; Neubauer, A.; Schaefer-Eckart, K.; Haenel, M.; Peceny, R.; Frickhofen, N.; Kiehl, M.; Giagounidis, A.; Goerner, M.; Repp, R.; Link, H.; Kiani, A.; Naumann, R.; Bruemmendorf, Th; Serve, H.; Ehninger, G.; Berdel, W. E.; Krug, U. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
